Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, Massachusetts 02142, USA.
Mol Cell Proteomics. 2012 May;11(5):148-59. doi: 10.1074/mcp.M111.016857. Epub 2012 Apr 14.
Ubiquitination plays a key role in protein degradation and signal transduction. Ubiquitin is a small protein modifier that is adducted to lysine residues by the combined function of E1, E2, and E3 enzymes and is removed by deubiquitinating enzymes. Characterization of ubiquitination sites is important for understanding the role of this modification in cellular processes and disease. However, until recently, large-scale characterization of endogenous ubiquitination sites has been hampered by the lack of efficient enrichment techniques. The introduction of antibodies that specifically recognize peptides with lysine residues that harbor a di-glycine remnant (K-ε-GG) following tryptic digestion has dramatically improved the ability to enrich and identify ubiquitination sites from cellular lysates. We used this enrichment technique to study the effects of proteasome inhibition by MG-132 and deubiquitinase inhibition by PR-619 on ubiquitination sites in human Jurkat cells by quantitative high performance mass spectrometry. Minimal fractionation of digested lysates prior to immunoaffinity enrichment increased the yield of K-ε-GG peptides three- to fourfold resulting in detection of up to ~3300 distinct K-GG peptides in SILAC triple encoded experiments starting from 5 mg of protein per label state. In total, we identify 5533 distinct K-ε-GG peptides of which 4907 were quantified in this study, demonstrating that the strategy presented is a practical approach to perturbational studies in cell systems. We found that proteasome inhibition by MG-132 and deubiquitinase inhibition by PR-619 induces significant changes to the ubiquitin landscape, but that not all ubiquitination sites regulated by MG-132 and PR-619 are likely substrates for the ubiquitin-proteasome system. Additionally, we find that the proteasome and deubiquitinase inhibitors studied induced only minor changes in protein expression levels regardless of the extent of regulation induced at the ubiquitin site level. We attribute this finding to the low stoichiometry of the majority ubiquitination sites identified in this study.
泛素化在蛋白质降解和信号转导中起着关键作用。泛素是一种小的蛋白质修饰物,通过 E1、E2 和 E3 酶的联合功能被添加到赖氨酸残基上,并被去泛素化酶去除。泛素化位点的特征对于理解这种修饰在细胞过程和疾病中的作用非常重要。然而,直到最近,由于缺乏有效的富集技术,大规模描述内源性泛素化位点的工作一直受到阻碍。专门识别在胰蛋白酶消化后带有二甘氨酸残基(K-ε-GG)的赖氨酸残基肽的抗体的引入,极大地提高了从细胞裂解物中富集和鉴定泛素化位点的能力。我们使用这种富集技术,通过定量高分辨率质谱研究蛋白酶体抑制剂 MG-132 和去泛素化酶抑制剂 PR-619 对人 Jurkat 细胞中泛素化位点的影响。在免疫亲和富集之前,对消化的裂解物进行最小程度的分级分离,可使 K-ε-GG 肽的产量增加 3 到 4 倍,从而在每个标签状态从 5mg 蛋白开始的 SILAC 三重编码实验中检测到多达约 3300 个不同的 K-GG 肽。总共,我们鉴定了 5533 个不同的 K-ε-GG 肽,其中 4907 个在本研究中进行了定量,这表明所提出的策略是细胞系统中扰动研究的一种实用方法。我们发现,MG-132 抑制蛋白酶体和 PR-619 抑制去泛素化酶都会显著改变泛素图谱,但并非所有由 MG-132 和 PR-619 调节的泛素化位点都可能是泛素-蛋白酶体系统的底物。此外,我们发现,所研究的蛋白酶体和去泛素化酶抑制剂在无论在泛素化位点水平上诱导的调节程度如何,对蛋白质表达水平的影响都很小。我们将这一发现归因于本研究中鉴定的大多数泛素化位点的低化学计量。